PELTHOS THERAPEUTICS INC PTHS

US Healthcare Biological Products, (No Diagnostic Substances)
$25.77
-8.0%
52w: $11.50 – $37.42

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
11.5024.4637.42
Jun 20, 2025 Jul 2, 2026
Institutional holders
17
+2 QoQ
13F value
$19.2M
-31.2% QoQ
Smart-money holders
5
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$13.0M
Q3 2025
$27.9M
Q4 2025
$19.2M
Q1 2026

Number of holders

14
Q3 2025
15
Q4 2025
17
Q1 2026

Who owns PTHS?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Murchinson Ltd. ★2Fundamental concentrated296.3K$6.2M2.5%+2.4%
Ikarian Capital, LLC ★2Fundamental diversified256.6K$5.4M0.8%+0.3%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical93.1K$2.0M0.0%
BOOTHBAY FUND MANAGEMENT, LLC Diversified mechanical81.9K$1.7M0.0%+1.5%
J. Goldman & Co LP Quant stat arb50.4K$1.1M0.0%-35.4%
CANTOR FITZGERALD, L. P. Quant stat arb41.4K$870K0.0%+18.4%
DIADEMA PARTNERS LP ★2Fundamental diversified24.8K$520K0.2%-0.9%
Knott David M Jr ★2Fundamental diversified21.1K$443K0.3%+9.3%
GEODE CAPITAL MANAGEMENT, LLC Index provider15.3K$321K0.0%+12.2%
Pale Fire Capital SE ★2Fundamental concentrated12.9K$271K0.0%+59.5%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical9.8K$206K0.0%
Persistent Asset Partners Ltd Quant stat arb6.0K$126K0.0%Held
Steward Partners Investment Advisory, LLC Diversified mechanical1.9K$40K0.0%Held
UBS Group AG Bank broker764$16K0.0%+76.0%
Farther Finance Advisors, LLC Wealth advisor40$8520.0%New
Aspect Partners, LLC Wealth advisor16$3360.0%New
CITIGROUP INC Bank broker1$210.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.